BTAIVSRXST• 3 Months (Normalized)
BTAI vs RXST (BioXcel Therapeutics Inc. vs RxSight Inc.)
Showing Closing Date Range from Jun, 18 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.07
-94.43%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
RXST Performance $5.4
+14.16%
RxSight Inc.
Normalized Baseline0.00%
Alpha Spread Margin RXST LEADS
-108.59%
RXST outperforming by 108.59%
BTAIRXST
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI RXST
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BTAI Price | BTAI Gain (%) | RXST Price | RXST Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.07 | -94.43% | $5.40 | +14.16% | -108.59% |
| Sep 15, 2026 | $0.04 | -96.28% | $5.62 | +18.82% | -115.10% |
| Sep 14, 2026 | $0.05 | -96.24% | $6.11 | +29.07% | -125.31% |
| Sep 11, 2026 | $0.05 | -95.75% | $6.02 | +27.27% | -123.02% |
| Sep 10, 2026 | $0.05 | -95.83% | $5.96 | +26.00% | -121.83% |
| Sep 09, 2026 | $0.05 | -96.08% | $6.33 | +33.83% | -129.91% |
| Sep 08, 2026 | $0.04 | -96.42% | $6.45 | +36.36% | -132.78% |
| Sep 04, 2026 | $0.07 | -93.84% | $6.38 | +34.78% | -128.62% |
| Sep 03, 2026 | $0.12 | -90.17% | $6.54 | +38.27% | -128.44% |
| Sep 02, 2026 | $0.11 | -91.08% | $7.03 | +48.63% | -139.71% |
| Sep 01, 2026 | $0.14 | -88.58% | $6.99 | +47.78% | -136.36% |
| Aug 31, 2026 | $0.16 | -86.42% | $7.33 | +54.97% | -141.39% |
| Aug 28, 2026 | $0.18 | -84.92% | $7.05 | +49.05% | -133.97% |
| Aug 27, 2026 | $0.72 | -40.08% | $6.61 | +39.75% | -79.83% |
| Aug 26, 2026 | $0.78 | -35.00% | $6.38 | +34.88% | -69.88% |
Page 1 of 5